Global Cancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Cancer Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
It is used in the treatment of cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cancer Drugs industry chain, the market status of Blood Cancer (Chemotherapy, Targeted Therapy), Breast Cancer (Chemotherapy, Targeted Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Drugs.
Regionally, the report analyzes the Cancer Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Chemotherapy, Targeted Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Drugs market.
Regional Analysis: The report involves examining the Cancer Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Drugs:
Company Analysis: Report covers individual Cancer Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Blood Cancer, Breast Cancer).
Technology Analysis: Report covers specific technologies relevant to Cancer Drugs. It assesses the current state, advancements, and potential future developments in Cancer Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Cancer Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cancer Drugs, with price, sales, revenue and global market share of Cancer Drugs from 2019 to 2024.
Chapter 3, the Cancer Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cancer Drugs.
Chapter 14 and 15, to describe Cancer Drugs sales channel, distributors, customers, research findings and conclusion.
It is used in the treatment of cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cancer Drugs industry chain, the market status of Blood Cancer (Chemotherapy, Targeted Therapy), Breast Cancer (Chemotherapy, Targeted Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Drugs.
Regionally, the report analyzes the Cancer Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Chemotherapy, Targeted Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Drugs market.
Regional Analysis: The report involves examining the Cancer Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Drugs:
Company Analysis: Report covers individual Cancer Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Blood Cancer, Breast Cancer).
Technology Analysis: Report covers specific technologies relevant to Cancer Drugs. It assesses the current state, advancements, and potential future developments in Cancer Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy (Biologic Therapy)
- Others
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory/Lung Cancer
- Other Cancers
- Roche
- Novartis
- Celgene
- Bristol-Myers Squibb
- Amgen
- Johnson & Johnson
- Pfizer
- Takeda
- Eli Lilly
- AstraZeneca
- Astellas
- Merck & Co.
- Sanofi
- Bayer
- Biogen Idec
- Eisai
- Teva
- Otsuka
- Merck KGaA
- Ipsen
- AbbVie
- Gilead Sciences
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Cancer Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cancer Drugs, with price, sales, revenue and global market share of Cancer Drugs from 2019 to 2024.
Chapter 3, the Cancer Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cancer Drugs.
Chapter 14 and 15, to describe Cancer Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cancer Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cancer Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy
1.3.5 Hormonal Therapy (Biologic Therapy)
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Cancer Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Blood Cancer
1.4.3 Breast Cancer
1.4.4 Gastrointestinal Cancer
1.4.5 Prostate Cancer
1.4.6 Respiratory/Lung Cancer
1.4.7 Other Cancers
1.5 Global Cancer Drugs Market Size & Forecast
1.5.1 Global Cancer Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Cancer Drugs Sales Quantity (2019-2030)
1.5.3 Global Cancer Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Cancer Drugs Product and Services
2.1.4 Roche Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Cancer Drugs Product and Services
2.2.4 Novartis Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Cancer Drugs Product and Services
2.3.4 Celgene Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgene Recent Developments/Updates
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Cancer Drugs Product and Services
2.4.4 Bristol-Myers Squibb Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments/Updates
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Cancer Drugs Product and Services
2.5.4 Amgen Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Amgen Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Cancer Drugs Product and Services
2.6.4 Johnson & Johnson Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Cancer Drugs Product and Services
2.7.4 Pfizer Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pfizer Recent Developments/Updates
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Cancer Drugs Product and Services
2.8.4 Takeda Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Takeda Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Cancer Drugs Product and Services
2.9.4 Eli Lilly Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Cancer Drugs Product and Services
2.10.4 AstraZeneca Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AstraZeneca Recent Developments/Updates
2.11 Astellas
2.11.1 Astellas Details
2.11.2 Astellas Major Business
2.11.3 Astellas Cancer Drugs Product and Services
2.11.4 Astellas Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Astellas Recent Developments/Updates
2.12 Merck & Co.
2.12.1 Merck & Co. Details
2.12.2 Merck & Co. Major Business
2.12.3 Merck & Co. Cancer Drugs Product and Services
2.12.4 Merck & Co. Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Merck & Co. Recent Developments/Updates
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Cancer Drugs Product and Services
2.13.4 Sanofi Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sanofi Recent Developments/Updates
2.14 Bayer
2.14.1 Bayer Details
2.14.2 Bayer Major Business
2.14.3 Bayer Cancer Drugs Product and Services
2.14.4 Bayer Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Bayer Recent Developments/Updates
2.15 Biogen Idec
2.15.1 Biogen Idec Details
2.15.2 Biogen Idec Major Business
2.15.3 Biogen Idec Cancer Drugs Product and Services
2.15.4 Biogen Idec Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Biogen Idec Recent Developments/Updates
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business
2.16.3 Eisai Cancer Drugs Product and Services
2.16.4 Eisai Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Eisai Recent Developments/Updates
2.17 Teva
2.17.1 Teva Details
2.17.2 Teva Major Business
2.17.3 Teva Cancer Drugs Product and Services
2.17.4 Teva Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Teva Recent Developments/Updates
2.18 Otsuka
2.18.1 Otsuka Details
2.18.2 Otsuka Major Business
2.18.3 Otsuka Cancer Drugs Product and Services
2.18.4 Otsuka Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Otsuka Recent Developments/Updates
2.19 Merck KGaA
2.19.1 Merck KGaA Details
2.19.2 Merck KGaA Major Business
2.19.3 Merck KGaA Cancer Drugs Product and Services
2.19.4 Merck KGaA Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Merck KGaA Recent Developments/Updates
2.20 Ipsen
2.20.1 Ipsen Details
2.20.2 Ipsen Major Business
2.20.3 Ipsen Cancer Drugs Product and Services
2.20.4 Ipsen Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Ipsen Recent Developments/Updates
2.21 AbbVie
2.21.1 AbbVie Details
2.21.2 AbbVie Major Business
2.21.3 AbbVie Cancer Drugs Product and Services
2.21.4 AbbVie Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 AbbVie Recent Developments/Updates
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Cancer Drugs Product and Services
2.22.4 Gilead Sciences Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Gilead Sciences Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CANCER DRUGS BY MANUFACTURER
3.1 Global Cancer Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Cancer Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Cancer Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Cancer Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Cancer Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Cancer Drugs Manufacturer Market Share in 2023
3.5 Cancer Drugs Market: Overall Company Footprint Analysis
3.5.1 Cancer Drugs Market: Region Footprint
3.5.2 Cancer Drugs Market: Company Product Type Footprint
3.5.3 Cancer Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cancer Drugs Market Size by Region
4.1.1 Global Cancer Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Cancer Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Cancer Drugs Average Price by Region (2019-2030)
4.2 North America Cancer Drugs Consumption Value (2019-2030)
4.3 Europe Cancer Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Cancer Drugs Consumption Value (2019-2030)
4.5 South America Cancer Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Cancer Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Cancer Drugs Sales Quantity by Type (2019-2030)
5.2 Global Cancer Drugs Consumption Value by Type (2019-2030)
5.3 Global Cancer Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cancer Drugs Sales Quantity by Application (2019-2030)
6.2 Global Cancer Drugs Consumption Value by Application (2019-2030)
6.3 Global Cancer Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Cancer Drugs Sales Quantity by Type (2019-2030)
7.2 North America Cancer Drugs Sales Quantity by Application (2019-2030)
7.3 North America Cancer Drugs Market Size by Country
7.3.1 North America Cancer Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Cancer Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Cancer Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Cancer Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Cancer Drugs Market Size by Country
8.3.1 Europe Cancer Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Cancer Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cancer Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Cancer Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Cancer Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Cancer Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Cancer Drugs Sales Quantity by Type (2019-2030)
10.2 South America Cancer Drugs Sales Quantity by Application (2019-2030)
10.3 South America Cancer Drugs Market Size by Country
10.3.1 South America Cancer Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Cancer Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cancer Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Cancer Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Cancer Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Cancer Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Cancer Drugs Market Drivers
12.2 Cancer Drugs Market Restraints
12.3 Cancer Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cancer Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cancer Drugs
13.3 Cancer Drugs Production Process
13.4 Cancer Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cancer Drugs Typical Distributors
14.3 Cancer Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Cancer Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cancer Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy
1.3.5 Hormonal Therapy (Biologic Therapy)
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Cancer Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Blood Cancer
1.4.3 Breast Cancer
1.4.4 Gastrointestinal Cancer
1.4.5 Prostate Cancer
1.4.6 Respiratory/Lung Cancer
1.4.7 Other Cancers
1.5 Global Cancer Drugs Market Size & Forecast
1.5.1 Global Cancer Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Cancer Drugs Sales Quantity (2019-2030)
1.5.3 Global Cancer Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Cancer Drugs Product and Services
2.1.4 Roche Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Cancer Drugs Product and Services
2.2.4 Novartis Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Cancer Drugs Product and Services
2.3.4 Celgene Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgene Recent Developments/Updates
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Cancer Drugs Product and Services
2.4.4 Bristol-Myers Squibb Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments/Updates
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Cancer Drugs Product and Services
2.5.4 Amgen Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Amgen Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Cancer Drugs Product and Services
2.6.4 Johnson & Johnson Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Cancer Drugs Product and Services
2.7.4 Pfizer Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pfizer Recent Developments/Updates
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Cancer Drugs Product and Services
2.8.4 Takeda Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Takeda Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Cancer Drugs Product and Services
2.9.4 Eli Lilly Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Cancer Drugs Product and Services
2.10.4 AstraZeneca Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AstraZeneca Recent Developments/Updates
2.11 Astellas
2.11.1 Astellas Details
2.11.2 Astellas Major Business
2.11.3 Astellas Cancer Drugs Product and Services
2.11.4 Astellas Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Astellas Recent Developments/Updates
2.12 Merck & Co.
2.12.1 Merck & Co. Details
2.12.2 Merck & Co. Major Business
2.12.3 Merck & Co. Cancer Drugs Product and Services
2.12.4 Merck & Co. Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Merck & Co. Recent Developments/Updates
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Cancer Drugs Product and Services
2.13.4 Sanofi Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sanofi Recent Developments/Updates
2.14 Bayer
2.14.1 Bayer Details
2.14.2 Bayer Major Business
2.14.3 Bayer Cancer Drugs Product and Services
2.14.4 Bayer Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Bayer Recent Developments/Updates
2.15 Biogen Idec
2.15.1 Biogen Idec Details
2.15.2 Biogen Idec Major Business
2.15.3 Biogen Idec Cancer Drugs Product and Services
2.15.4 Biogen Idec Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Biogen Idec Recent Developments/Updates
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business
2.16.3 Eisai Cancer Drugs Product and Services
2.16.4 Eisai Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Eisai Recent Developments/Updates
2.17 Teva
2.17.1 Teva Details
2.17.2 Teva Major Business
2.17.3 Teva Cancer Drugs Product and Services
2.17.4 Teva Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Teva Recent Developments/Updates
2.18 Otsuka
2.18.1 Otsuka Details
2.18.2 Otsuka Major Business
2.18.3 Otsuka Cancer Drugs Product and Services
2.18.4 Otsuka Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Otsuka Recent Developments/Updates
2.19 Merck KGaA
2.19.1 Merck KGaA Details
2.19.2 Merck KGaA Major Business
2.19.3 Merck KGaA Cancer Drugs Product and Services
2.19.4 Merck KGaA Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Merck KGaA Recent Developments/Updates
2.20 Ipsen
2.20.1 Ipsen Details
2.20.2 Ipsen Major Business
2.20.3 Ipsen Cancer Drugs Product and Services
2.20.4 Ipsen Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Ipsen Recent Developments/Updates
2.21 AbbVie
2.21.1 AbbVie Details
2.21.2 AbbVie Major Business
2.21.3 AbbVie Cancer Drugs Product and Services
2.21.4 AbbVie Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 AbbVie Recent Developments/Updates
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Cancer Drugs Product and Services
2.22.4 Gilead Sciences Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Gilead Sciences Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CANCER DRUGS BY MANUFACTURER
3.1 Global Cancer Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Cancer Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Cancer Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Cancer Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Cancer Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Cancer Drugs Manufacturer Market Share in 2023
3.5 Cancer Drugs Market: Overall Company Footprint Analysis
3.5.1 Cancer Drugs Market: Region Footprint
3.5.2 Cancer Drugs Market: Company Product Type Footprint
3.5.3 Cancer Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cancer Drugs Market Size by Region
4.1.1 Global Cancer Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Cancer Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Cancer Drugs Average Price by Region (2019-2030)
4.2 North America Cancer Drugs Consumption Value (2019-2030)
4.3 Europe Cancer Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Cancer Drugs Consumption Value (2019-2030)
4.5 South America Cancer Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Cancer Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Cancer Drugs Sales Quantity by Type (2019-2030)
5.2 Global Cancer Drugs Consumption Value by Type (2019-2030)
5.3 Global Cancer Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cancer Drugs Sales Quantity by Application (2019-2030)
6.2 Global Cancer Drugs Consumption Value by Application (2019-2030)
6.3 Global Cancer Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Cancer Drugs Sales Quantity by Type (2019-2030)
7.2 North America Cancer Drugs Sales Quantity by Application (2019-2030)
7.3 North America Cancer Drugs Market Size by Country
7.3.1 North America Cancer Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Cancer Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Cancer Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Cancer Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Cancer Drugs Market Size by Country
8.3.1 Europe Cancer Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Cancer Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cancer Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Cancer Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Cancer Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Cancer Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Cancer Drugs Sales Quantity by Type (2019-2030)
10.2 South America Cancer Drugs Sales Quantity by Application (2019-2030)
10.3 South America Cancer Drugs Market Size by Country
10.3.1 South America Cancer Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Cancer Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cancer Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Cancer Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Cancer Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Cancer Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Cancer Drugs Market Drivers
12.2 Cancer Drugs Market Restraints
12.3 Cancer Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cancer Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cancer Drugs
13.3 Cancer Drugs Production Process
13.4 Cancer Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cancer Drugs Typical Distributors
14.3 Cancer Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
